Squarepoint’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 3120 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 3126 |
|
|
2024
Q4 | – | Sell |
-18,566
| Closed | -$835K | – | 3131 |
|
|
2024
Q3 | $835K | Buy |
18,566
+8,743
| +89% | +$393K | ﹤0.01% | 1518 |
|
|
2024
Q2 | $340K | Buy |
+9,823
| New | +$340K | ﹤0.01% | 1904 |
|
|
2023
Q1 | – | Sell |
-21,770
| Closed | -$238K | – | 2674 |
|
|
2022
Q4 | $238K | Sell |
21,770
-55,092
| -72% | -$601K | ﹤0.01% | 1807 |
|
|
2022
Q3 | $648K | Buy |
76,862
+22,186
| +41% | +$187K | ﹤0.01% | 1294 |
|
|
2022
Q2 | $432K | Buy |
54,676
+40,866
| +296% | +$323K | ﹤0.01% | 1428 |
|
|
2022
Q1 | $327K | Sell |
13,810
-46,680
| -77% | -$1.11M | ﹤0.01% | 1690 |
|
|
2021
Q4 | $2.07M | Buy |
+60,490
| New | +$2.07M | 0.01% | 849 |
|
|
2021
Q1 | – | Sell |
-16,893
| Closed | -$341K | – | 2949 |
|
|
2020
Q4 | $341K | Buy |
+16,893
| New | +$341K | ﹤0.01% | 1777 |
|
|
2020
Q3 | – | Sell |
-118,120
| Closed | -$3.41M | – | 2615 |
|
|
2020
Q2 | $3.41M | Buy |
118,120
+81,037
| +219% | +$2.34M | 0.06% | 459 |
|
|
2020
Q1 | $262K | Sell |
37,083
-56,020
| -60% | -$396K | 0.01% | 1353 |
|
|
2019
Q4 | $656K | Buy |
93,103
+9,069
| +11% | +$63.9K | ﹤0.01% | 1571 |
|
|
2019
Q3 | $1.01M | Sell |
84,034
-18,303
| -18% | -$220K | 0.01% | 1201 |
|
|
2019
Q2 | $1.24M | Buy |
102,337
+57,560
| +129% | +$697K | 0.01% | 1116 |
|
|
2019
Q1 | $563K | Buy |
44,777
+18,973
| +74% | +$239K | 0.01% | 1403 |
|
|
2018
Q4 | $174K | Sell |
25,804
-10,306
| -29% | -$69.5K | ﹤0.01% | 1711 |
|
|
2018
Q3 | $372K | Sell |
36,110
-12,357
| -25% | -$127K | ﹤0.01% | 1442 |
|
|
2018
Q2 | $326K | Buy |
48,467
+31,936
| +193% | +$215K | ﹤0.01% | 1347 |
|
|
2018
Q1 | $142K | Buy |
+16,531
| New | +$142K | ﹤0.01% | 1536 |
|